Superworth

IDEXX Laboratories forward PE IDXX

Share price divided by analysts' consensus earnings for the next twelve months, since 1996.

Today, Oct 23, 2026
35.9×
10-year median
50.3×
Against its 10-year history
5th
percentile: 0 is its lowest day, 100 its highest
10-year range
32.0× to 92.5×
Peer median
26.4×

IDEXX Laboratories' forward PE is 35.9× as of Oct 23, 2026.

That is below its ten-year median of 50.3×, lower than on 95% of days in the last ten years.

Over that time it ranged from 32.0× in Apr 2025 to 92.5× in Sep 2021.

The median for 10 diagnostics and research stocks of a similar size is 26.4×.

Forward PE over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far35.9×32.4×51.1×
202549.2×32.0×53.8×
202435.5×35.3×54.0×
202353.4×38.8×57.3×
202244.4×36.6×72.6×
202186.9×65.1×92.5×
202070.9×35.2×70.9×
201956.1×42.8×65.6×
201842.4×42.2×64.1×
201744.2×41.7×61.2×
201647.1×34.7×48.5×
201538.2×33.0×44.7×
201439.7×31.6×40.4×
201331.8×25.0×32.6×
201228.8×26.9×32.5×
201126.9×24.2×34.5×
201030.6×25.0×33.4×
200927.6×18.7×29.9×
200822.1×18.3×38.3×
200735.6×27.5×38.9×

Against its peers

Companies in Medical - Diagnostics & Research nearest IDEXX Laboratories' size, closest first, today.

CompanyForward PE
IDXXIDEXX Laboratories35.9×
WATWaters29.2×
IQVIQVIA20.5×
ILMNIllumina47.2×
AAgilent Technologies26.4×
MTDMettler-Toledo International33.9×
DGXQuest Diagnosticsn/m
LHLabcorp17.4×
MEDPMedpacen/m
RVTYRevvityn/m
DHRDanaher25.4×
Peer median26.4×

Where IDEXX Laboratories ranks

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on IDEXX Laboratories

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.